Nicox Raises €15 million in Private Placement
Press Release Nicox Raises €15 million in Private Placement Strengthens financial position in advance of upcoming key value inflection...
Staff
Nicox Raises €15 million in Private Placement
Press Release Nicox Raises €15 million in Private Placement Strengthens financial position in advance of upcoming key value inflection...
AB Science announces that confirmatory Phase 3 study AB12005 with masitinib in first line pancreatic cancer with pain was successful
Paris, December 4, 2020, 8.30am AB Science announces that confirmatory Phase 3 study AB12005 with masitinibin first line pancreatic cancer...
BioCryst Announces FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
ORLADEYO™ (berotralstat) capsules ORLADEYO™ (berotralstat) capsules 150 mg —Significant and sustained reduction in HAE attacks— —Oral, once-daily prophylactic option enables...
Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures...
Seer Announces Pricing of Initial Public Offering
REDWOOD CITY, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific...
Afya Limited Announces Third Quarter and Nine Months 2020 Financial Results
Tracking in Line to Meet 2H20 GuidanceExpands Digital Health Product Offering with Three Strategic Acquisitions NOVA LIMA, Brazil and MINAS...
Cambium Networks Corporation Announces Pricing of Secondary Offering
ROLLING MEADOWS, Ill., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (Nasdaq: CMBM) (“Cambium”), a provider of wireless networking...
ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
Webcast scheduled for Monday, December 7 at 4:00 pm CET/10:00 am ETLYON, France and CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE...
Study by Intermountain Researchers to Determine If Blood Thinners Prevent Clots, Illness Severity in COVID-19 Patients
Salt Lake City, Utah, Dec. 03, 2020 (GLOBE NEWSWIRE) -- As part of a national movement to develop treatments and...
CooperCompanies Announces Fourth Quarter and Full Year 2020 Results
SAN RAMON, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth...
Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that it will...
Indus Holdings, Inc. Announces Updated Fourth Quarter Guidance
SALINAS, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus” or the “Company”) (CSE:INDS; OTCQX: INDXF), a leading,...
Silk Road Medical Announces Changes to Board of Directors
SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the...
These Tips Make Family Caregiving During the Holidays a Bit Easier This Year
Elmcroft assisted living communities share expert insights for adult children thinking about what’s next for a senior loved one.LAKE OSWEGO,...
Trident Brands Incorporated Announces New Investor Agreement to Convert Debt to Equity
All figures are in USD$ Brookfield, WI, Dec. 03, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Trident Brands, Inc (“Trident”)...
IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bio’s Gamma Delta T-cell product candidate, at ASH 2020
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous...
Issuance of a 4th tranche of €1.5 million of notes convertible into new shares
ISSUANCE OF A 4th TRANCHE OF €1.5 MILLION OF NOTES CONVERTIBLE INTO NEW SHARES ·DEINOVE immediately strengthens its...
Tauriga Sciences Inc. Fully Repays and Retires $88,333.00 Face Value 8.00% Convertible Debenture Issued on May 18, 2020
DECEMBER 2nd PR Hanukkah Special Gift Pack – Limited Edition (613 Packs) NEW YORK, NY, Dec. 03, 2020 (GLOBE NEWSWIRE)...
Nanox Announces Successful Demonstration of the Nanox.ARC Prototype During RSNA 2020
Live demonstration featured a range of 2D and 3D imaging proceduresNEVE ILAN, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- NANO-X...